A. BEYTUR Et Al. , "Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats," CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.69, no.1, pp.207-213, 2012
BEYTUR, A. Et Al. 2012. Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats. CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.69, no.1 , 207-213.
BEYTUR, A., ÇİFTÇİ, O., OĞUZ, F., OĞUZTÜRK, H., & YILMAZ, F., (2012). Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats. CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.69, no.1, 207-213.
BEYTUR, ALİ Et Al. "Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats," CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.69, no.1, 207-213, 2012
BEYTUR, ALİ Et Al. "Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats." CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.69, no.1, pp.207-213, 2012
BEYTUR, A. Et Al. (2012) . "Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats." CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.69, no.1, pp.207-213.
@article{article, author={ALİ BEYTUR Et Al. }, title={Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats}, journal={CANCER CHEMOTHERAPY AND PHARMACOLOGY}, year=2012, pages={207-213} }